Skip to main content
Clinical Trials/NCT00181116
NCT00181116
Completed
Phase 4

Efficacy of Levetiracetam for Language Dysfunction Associated With Benign Epilepsy With Centrotemporal Spikes

Johns Hopkins University1 site in 1 country6 target enrollmentMarch 2005
ConditionsEpilepsy

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Epilepsy
Sponsor
Johns Hopkins University
Enrollment
6
Locations
1
Primary Endpoint
Language improvement
Status
Completed
Last Updated
17 years ago

Overview

Brief Summary

This study is designed to test if the language problems commonly seen in children with benign rolandic epilepsy would improve by switching anticonvulsants to levetiracetam.

Detailed Description

This is a 6 month study in which children on another anticonvulsant would have EEG, language testing, and a clinic visit at baseline. They would then be rapidly transitioned off of their current anticonvulsant and onto levetiracetam (Keppra). Repeat EEG and language testing would be done after 6 months to evaluate for improvement.

Registry
clinicaltrials.gov
Start Date
March 2005
End Date
September 2006
Last Updated
17 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Ages 6-12
  • Benign rolandic epilepsy
  • Language difficulties as reported by parents or teachers
  • On another anticonvulsant other than levetiracetam

Exclusion Criteria

  • Prior use of levetiracetam
  • On 2 or more anticonvulsants
  • Language problems prior to epilepsy
  • Another seizure disorder
  • Status epilepticus within the past 6 months
  • Significant psychiatric disease
  • Progressive neurologic disease

Outcomes

Primary Outcomes

Language improvement

Secondary Outcomes

  • Seizure control

Study Sites (1)

Loading locations...

Similar Trials